Cargando…
Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging
Fibroblast Growth Factor 21 (FGF21), Growth Differentiation Factor 15 (GDF15), and Humanin (HN) are mitochondrial stress-related mitokines, whose role in health and disease is still debated. In this study, we confirmed that their plasma levels are positively correlated with age in healthy subjects....
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110619/ https://www.ncbi.nlm.nih.gov/pubmed/33131010 http://dx.doi.org/10.1007/s11357-020-00287-w |
_version_ | 1783690332693594112 |
---|---|
author | Conte, Maria Sabbatinelli, Jacopo Chiariello, Antonio Martucci, Morena Santoro, Aurelia Monti, Daniela Arcaro, Marina Galimberti, Daniela Scarpini, Elio Bonfigli, Anna Rita Giuliani, Angelica Olivieri, Fabiola Franceschi, Claudio Salvioli, Stefano |
author_facet | Conte, Maria Sabbatinelli, Jacopo Chiariello, Antonio Martucci, Morena Santoro, Aurelia Monti, Daniela Arcaro, Marina Galimberti, Daniela Scarpini, Elio Bonfigli, Anna Rita Giuliani, Angelica Olivieri, Fabiola Franceschi, Claudio Salvioli, Stefano |
author_sort | Conte, Maria |
collection | PubMed |
description | Fibroblast Growth Factor 21 (FGF21), Growth Differentiation Factor 15 (GDF15), and Humanin (HN) are mitochondrial stress-related mitokines, whose role in health and disease is still debated. In this study, we confirmed that their plasma levels are positively correlated with age in healthy subjects. However, when looking at patients with type 2 diabetes (T2D) or Alzheimer’s disease (AD), two age-related diseases sharing a mitochondrial impairment, we found that GDF15 is elevated in T2D but not in AD and represents a risk factor for T2D complications, while FGF21 and HN are lower in AD but not in T2D. Moreover, FGF21 reaches the highest levels in centenarian’ offspring, a model of successful aging. As a whole, these data indicate that (i) the adaptive mitokine response observed in healthy aging is lost in age-related diseases, (ii) a common expression pattern of mitokines does not emerge in T2D and AD, suggesting an unpredicted complexity and disease-specificity, and (iii) FGF21 emerges as a candidate marker of healthy aging. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s11357-020-00287-w) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-8110619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-81106192021-05-13 Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging Conte, Maria Sabbatinelli, Jacopo Chiariello, Antonio Martucci, Morena Santoro, Aurelia Monti, Daniela Arcaro, Marina Galimberti, Daniela Scarpini, Elio Bonfigli, Anna Rita Giuliani, Angelica Olivieri, Fabiola Franceschi, Claudio Salvioli, Stefano GeroScience Original Article Fibroblast Growth Factor 21 (FGF21), Growth Differentiation Factor 15 (GDF15), and Humanin (HN) are mitochondrial stress-related mitokines, whose role in health and disease is still debated. In this study, we confirmed that their plasma levels are positively correlated with age in healthy subjects. However, when looking at patients with type 2 diabetes (T2D) or Alzheimer’s disease (AD), two age-related diseases sharing a mitochondrial impairment, we found that GDF15 is elevated in T2D but not in AD and represents a risk factor for T2D complications, while FGF21 and HN are lower in AD but not in T2D. Moreover, FGF21 reaches the highest levels in centenarian’ offspring, a model of successful aging. As a whole, these data indicate that (i) the adaptive mitokine response observed in healthy aging is lost in age-related diseases, (ii) a common expression pattern of mitokines does not emerge in T2D and AD, suggesting an unpredicted complexity and disease-specificity, and (iii) FGF21 emerges as a candidate marker of healthy aging. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s11357-020-00287-w) contains supplementary material, which is available to authorized users. Springer International Publishing 2020-10-31 /pmc/articles/PMC8110619/ /pubmed/33131010 http://dx.doi.org/10.1007/s11357-020-00287-w Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Conte, Maria Sabbatinelli, Jacopo Chiariello, Antonio Martucci, Morena Santoro, Aurelia Monti, Daniela Arcaro, Marina Galimberti, Daniela Scarpini, Elio Bonfigli, Anna Rita Giuliani, Angelica Olivieri, Fabiola Franceschi, Claudio Salvioli, Stefano Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging |
title | Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging |
title_full | Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging |
title_fullStr | Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging |
title_full_unstemmed | Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging |
title_short | Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging |
title_sort | disease-specific plasma levels of mitokines fgf21, gdf15, and humanin in type ii diabetes and alzheimer’s disease in comparison with healthy aging |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110619/ https://www.ncbi.nlm.nih.gov/pubmed/33131010 http://dx.doi.org/10.1007/s11357-020-00287-w |
work_keys_str_mv | AT contemaria diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT sabbatinellijacopo diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT chiarielloantonio diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT martuccimorena diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT santoroaurelia diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT montidaniela diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT arcaromarina diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT galimbertidaniela diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT scarpinielio diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT bonfigliannarita diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT giulianiangelica diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT olivierifabiola diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT franceschiclaudio diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging AT salviolistefano diseasespecificplasmalevelsofmitokinesfgf21gdf15andhumaninintypeiidiabetesandalzheimersdiseaseincomparisonwithhealthyaging |